1215821-44-5
Chemical Structure
Fexofenadine-d10 hydrochloride
Synonym(s): MDL-16455-d10 hydrochloride; Terfenadine carboxylate-d10 hydrochloride
- CAS No.: 1215821-44-5
- Formula:C32H30D10ClNO4
- Molecular Weight:548.18
IUPAC Name: 2-(4-(1-hydroxy-4-(4-(hydroxybis(phenyl-d5)methyl)piperidin-1-yl)butyl)phenyl)-2-methylpropanoic acid hydrochloride
InChIKey: RRJFVPUCXDGFJB-MQHVTZQPSA-N
SMILES: OC(C1=C([2H])C([2H])=C([2H])C([2H])=C1[2H])(C2=C([2H])C([2H])=C([2H])C([2H])=C2[2H])C3CCN(CC3)CCCC(C4=CC=C(C=C4)C(C)(C)C(O)=O)O.Cl
Biological Activity: Fexofenadine-d10 (hydrochloride) is deuterium labeled Fexofenadine (hydrochloride). Fexofenadine hydrochloride (MDL-16455 hydrochloride), a H1R antagonist, is an anti-allergic agent used in seasonal allergic rhinitis and chronic idiopathic urticarial (person aged ≥16 years)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Fexofenadine-d10 hydrochloride | Fexofenadine-d10 (hydrochloride) is deuterium labeled Fexofenadine (hydrochloride). Fexofenadine hydrochloride (MDL-16455 hydrochloride), a H1R antagonist, is an anti-allergic agent used in seasonal allergic rhinitis and chronic idiopathic urticarial (person aged ≥16 years). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fexofenadine hydrochloride (Standard) | ≥98% | Fexofenadine (hydrochloride) (Standard) is the analytical standard of Fexofenadine (hydrochloride). This product is intended for research and analytical applications. Fexofenadine (MDL-16455) hydrochloride is an orally active and nonsedative H1 receptor antagonist. Fexofenadine hydrochloride can be used in allergic rhinitis and chronic idiopathic urticarial research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fexofenadine hydrochloride | 99.94% | Fexofenadine (MDL-16455) hydrochloride is an orally active and nonsedative H1 receptor antagonist. Fexofenadine hydrochloride can be used in allergic rhinitis and chronic idiopathic urticarial research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
